NCT06431451View on ClinicalTrials.gov

The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Gastrointestinal Stromal Tumors
Trial Locations (1)

510080

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER